Vaccine against SARS-CoV-2: Challenges and considerations

Area of Science:

• Virology
• Vaccinology
• Biotechnology

Background:

• The global health crisis caused by SARS-CoV-2 necessitates rapid vaccine development.
• Understanding past challenges in vaccine development is crucial for current SARS-CoV-2 vaccine strategies.
• Limited knowledge of SARS-CoV-2 initially required adaptable and efficient development approaches.

Purpose of the Study:

• To discuss the application of nucleic acid vaccines (DNA and RNA) for viral infections, particularly in pandemic scenarios.
• To highlight the potential benefits of nucleic acid vaccines compared to conventional vaccine platforms.
• To review current nucleic acid vaccine candidates for viral infections and their clinical trial challenges.

Main Methods:

• Literature review and commentary on existing research regarding nucleic acid vaccine technology.
• Analysis of potential advantages of nucleic acid vaccines over traditional vaccine types.
• Discussion of challenges encountered by nucleic acid vaccines in progressing to clinical trials.

Main Results:

• Nucleic acid vaccines present distinct advantages, including rapid development and adaptability.
• Several nucleic acid vaccine candidates are under investigation for various viral infections.
• Challenges remain in the clinical translation and regulatory approval of these novel vaccine types.

Conclusions:

• Nucleic acid vaccine technology holds significant promise for addressing viral pandemics like SARS-CoV-2.
• Overcoming challenges in clinical trials is key to realizing the full potential of these advanced vaccines.
• Continued research and development are essential for effective pandemic preparedness using nucleic acid vaccine platforms.